BEN
40
3
MDLZ
36
6
AXP
67
4
HST
57
4
HPE
38
2
USB
50
4
GLW
48
4
CNP
54
4
URI
39
3
FLR
52
2
HAL
34
7
AON
30
2
PNR
60
3
LOW
46
3
ORCL
55
6
GIS
37
2
NUE
41
2
QCOM
59
3
BMY
33
-2
CVX
17
3
BEN
40
3
MDLZ
36
6
AXP
67
4
HST
57
4
HPE
38
2
USB
50
4
GLW
48
4
CNP
54
4
URI
39
3
FLR
52
2
HAL
34
7
AON
30
2
PNR
60
3
LOW
46
3
ORCL
55
6
GIS
37
2
NUE
41
2
QCOM
59
3
BMY
33
-2
CVX
17
3
Financhill
Back

Avenue Therapeutics 10K Form

Sell
20

ATXI
Avenue Therapeutics

Last Price:
$1.74
Seasonality Move:
9.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATXI News And Ratings

See the #1 stock for the next 7 days that we like better than ATXI

ATXI Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-2.9M
Price / Cash Flow: 0
Annual Sales: $1.63
Price / Book: 1.35

Profitability

EPS (TTM): -21.87480
Net Income (TTM): $-14M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Avenue Therapeutics Earnings Forecast

Key Avenue Therapeutics Financial Ratios

  • The Interest Expense is -3.20% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Avenue Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ATXI
CUSIP: 05360L
Website: avenuetx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATXI Technical Analysis vs Fundamental Analysis

Sell
20
Avenue Therapeutics (ATXI) is a Sell

Is Avenue Therapeutics a Buy or a Sell?